Sanofi is weighing a takeover bid for U.S. respiratory drugmaker Insmed
Insmed stock rose as much as 24% on Thursday, and any deal could be weeks away, according to Bloomberg
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Sanofi Weighs Takeover of US Drugmaker Insmed bloomberg.com